Correlation Between Relief Therapeutics and Cellectar Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Relief Therapeutics and Cellectar Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relief Therapeutics and Cellectar Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Relief Therapeutics Holding and Cellectar Biosciences, you can compare the effects of market volatilities on Relief Therapeutics and Cellectar Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relief Therapeutics with a short position of Cellectar Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relief Therapeutics and Cellectar Biosciences.

Diversification Opportunities for Relief Therapeutics and Cellectar Biosciences

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Relief and Cellectar is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Relief Therapeutics Holding and Cellectar Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cellectar Biosciences and Relief Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relief Therapeutics Holding are associated (or correlated) with Cellectar Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cellectar Biosciences has no effect on the direction of Relief Therapeutics i.e., Relief Therapeutics and Cellectar Biosciences go up and down completely randomly.

Pair Corralation between Relief Therapeutics and Cellectar Biosciences

If you would invest  313.00  in Relief Therapeutics Holding on September 13, 2024 and sell it today you would earn a total of  0.00  from holding Relief Therapeutics Holding or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy0.8%
ValuesDaily Returns

Relief Therapeutics Holding  vs.  Cellectar Biosciences

 Performance 
       Timeline  
Relief Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Relief Therapeutics Holding has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Relief Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Cellectar Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cellectar Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Relief Therapeutics and Cellectar Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Relief Therapeutics and Cellectar Biosciences

The main advantage of trading using opposite Relief Therapeutics and Cellectar Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relief Therapeutics position performs unexpectedly, Cellectar Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cellectar Biosciences will offset losses from the drop in Cellectar Biosciences' long position.
The idea behind Relief Therapeutics Holding and Cellectar Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals